Roundup
Roundup Criteria
The criteria below is a list of standard filters. We can customize the criteria based on your requirements.
- Direct exposure to Roundup from work or home use for 5 years or longer
- Diagnosed with any of the following cancers :
- Adult T-cell lymphoma/leukemia (T-ATLL)
- Aggressive NK-cell leukemia (NK-AL)
- Anaplastic large T/null-cell lymphoma (T/N-ALCL)
- Blastic mantle cell lymphoma (B- BMCL)
- Blastic plasmacytoid dendritic cell neoplasm (BPDCN)
- B-lymphoblastic leukemia (BP-ALL)
- B-lymphoblastic lymphoma (BP-LBL)
- B-prolymphocytic leukemia (B-PLL)
- Burkitt lymphoma (B-BL)
- Chronic lymphocytic leukemia (B-CLL)
- Composite lymphoma (CL: % %)
- Cutaneous CD4-positive small/medium T-cell lymphoma (T-CCD4SML)
- Cutaneous CD8-positive aggressive epidermotropic cytotoxic T-cell lymphoma (T-CCD8ECL)
- Dendritic/histiocytic neoplasm (DHN)
- Diffuse follicular lymphoma (B-DFL)
- Diffuse large B-cell lymphoma (B-DLCL)
- Diffuse lymphocyte-predominant (HD-LP-D)
- Diffuse mantle cell lymphoma (B-DMCL)
- EBV-driven lymphoproliferative disorder (EBVLD)
- Enteropathy-type T-cell lymphoma (T-EATL)
- Extranodal marginal zone B-cell Lymphoma (B-EMZL)
- Follicular lymphoma (B-FL)
- Hairy cell leukemia (B-HCL)
- Hepatosplenic T-cell lymphoma (T-HSGDL)
- Interfollicular (HD-IF)
- Langherns cell histiocytosis (LCH)
- Lymphocyte-depleted (HD-LD)
- Lymphocyte-rich (HD-LR)
- Lymphoplasmacytic lymphoma (B-LPL)
- Malignant lymphoma unclassifiable (ML-UC)
- Mantle cell lymphoma (B-MCL-IS)
- Mast cell disease (MCD)
- Mixed cellularity (HD-MC)
- Mycosis fungoides (T-MF)
- Nasal NK-T-cell lymphoma (NK/T)
- NK-cell granular lymphocytic proliferation (NK-GLP)
- Nodal marginal zone B-cell lymphoma (B-NMZL)
- Nodular lymphocyte-predominant (HD-LP-N)
- Nodular mantle cell lymphoma (B-NMCL)
- Nodular sclerosis (HD-NS)
- Non-hodgin lymphoma (NHL)
- Not otherwise specified (HD-NOS)
- Peripheral gamma-delta T-cell lymphoma (T-PGDL)
- Peripheral T-cell lymphoma (T-PTCL)
- Plasma cell dyscrasia (B-PCD)
- Plasma cell myeloma (B-PCM)
- Plasmacytoma (B-PC)
- Post-transplantation lymphoproliferative disorder (PTLD)
- Primary cutaneous CD30-positive lymphoproliferative disorder (T-PCLPD-CD30)
- Sezary syndrome (T-SS)
- Small lymphocytic lymphoma (B-SLL)
- Splenic diffuse red pulp small B-cell lymphoma (B-SDRPL)
- Splenic marginal zone B-cell lymphoma (B-SMZL)
- Subcutaneous panniculitis-like T-cell lymphoma (T-SPTL)
- T-cell granular lymphocytic proliferation (T-GLP)
- T-cell lymphoproliferative disorder of childhood, Epstein-Barr virus positive (TLPDC-EBV)
- T-lymphoblastic leukemia (TP-ALL)
- T-lymphoblastic lymphoma (TP-LBL)
- T-prolyrnphocytic leukemia (T-PLL)
- Unclassifieable B-cell lymphoma (B-UCL)
- No previous diagnosis
- No legal representation